Phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: SWOG/Alliance/ECOG-ACRIN/NCIC Clinical Trials Group/NRG Oncology study S0307.

被引：20

作者：

Gralow, Julie

Barlow, William E.

Paterson, Alexander H. G.

Lew, Danika

Stopeck, Alison

Hayes, Daniel F.

Hershman, Dawn L.

Schubert, Mark

Clemons, Mark J.

Van Poznak, Catherine H.

Dees, Elizabeth Claire

Ingle, James N.

Falkson, Carla Isadora

Elias, Anthony D.

Messino, Michael J.

Margolis, Jeffrey H.

Dakhil, Shaker R.

Chew, Helen K.

Livingston, Robert B.

Hortobagyi, Gabriel N.

机构：

[1] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA

[2] Canc Rsrch & Biostats, Seattle, WA USA

[3] Tom Baker Canc Clin, Calgary, AB, Canada

[4] Southwest Oncol Grp Stat Ctr, Seattle, WA USA

[5] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA

[6] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[7] Columbia Univ, Med Ctr, New York, NY USA

[8] Seattle Canc Care Alliance, Seattle, WA USA

[9] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada

[10] Univ N Carolina, Chapel Hill, NC USA

[11] Mayo Clin, Rochester, MN USA

[12] Univ Alabama Birmingham, Birmingham, AL USA

[13] Univ Colorado, Ctr Canc, Aurora, CO USA

[14] Canc Care WNC PA, Asheville, NC USA

[15] Oakland Med Grp, West Bloomfield, MI USA

[16] Canc Ctr Kansas, Wichita, KS USA

[17] UC Davis Med Ctr, Sacramento, CA USA

[18] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.503

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

503

引用

页数：1